HIGH MATERNAL SERUM CHORIONIC-GONADOTROPIN LEVEL IN DOWNS-SYNDROME PREGNANCIES IS CAUSED BY ELEVATION OF BOTH SUBUNITS MESSENGER-RIBONUCLEIC-ACID LEVEL IN TROPHOBLASTS

被引:35
作者
ELDARGEVA, T
HOCHBERG, A
DEGROOT, N
WEINSTEIN, D
机构
[1] HEBREW UNIV JERUSALEM, ALEXANDER SILBERMAN INST LIFE SCI, DEPT BIOL CHEM, IL-91904 JERUSALEM, ISRAEL
[2] HADASSAH UNIV HOSP, DEPT OBSTET & GYNECOL, IL-91120 JERUSALEM, ISRAEL
关键词
D O I
10.1210/jc.80.12.3528
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A unique product of human placenta is CG. Its concentration in maternal blood rises exponentially until 9-10 weeks' gestation, thereafter, it decreases to about 20% of the maximum, remaining constant from 16-17 until 40 weeks. High second-trimester maternal blood level indicates an increased risk for Downs' Syndrome (DS). This study's aim was to determine whether changes occur in the genetic expression of CG subunits in cultured trisomy-21 trophoblasts compared with various gestational age controls. Second-trimester trisomy-21 trophoblasts secrete 10 times more CG than gestational age-matched controls during the first day in culture: 878 (range, 235-2230) IU/g vs. 87 (range, 20-150) IU/g (P < 0.05). This high secretion closely resembles quantities secreted by first-trimester normal trophoblasts: 7500 (range, 3,850-10,000) IU/g. Both subunits' messenger RNA content are substantially increased, CG beta much more than CG alpha, although these genes are not located on chromosome 21. We conclude that at least one cause of high second-trimester maternal blood CG in DS pregnancies is a rise in alpha and beta CG messenger RNA levels in the trophoblast. We propose that at 12-14 weeks, when rapid decrease in maternal blood CG levels can be found, higher than normal values may indicate an increased risk for DS.
引用
收藏
页码:3528 / 3531
页数:4
相关论文
共 26 条
[1]   THE EFFECTS OF VARIOUS HORMONES ON HUMAN CHORIONIC-GONADOTROPIN PRODUCTION IN EARLY AND LATE PLACENTAL EXPLANT CULTURES [J].
AHMED, NA ;
MURPHY, BEP .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1988, 159 (05) :1220-1227
[2]  
ARMITAGE P, 1987, STATISTICAL METHODS, P408
[3]   ABNORMAL MATERNAL SERUM CHORIONIC-GONADOTROPIN LEVELS IN PREGNANCIES WITH FETAL CHROMOSOME-ABNORMALITIES [J].
BOGART, MH ;
PANDIAN, MR ;
JONES, OW .
PRENATAL DIAGNOSIS, 1987, 7 (09) :623-630
[4]  
BOOTHBY M, 1981, J BIOL CHEM, V256, P5121
[5]   1ST-TRIMESTER MATERNAL SERUM BIOCHEMICAL INDICATORS IN DOWN SYNDROME [J].
BROCK, DJH ;
BARRON, L ;
HOLLOWAY, S ;
LISTON, WA ;
HILLIER, SG ;
SEPPALA, M .
PRENATAL DIAGNOSIS, 1990, 10 (04) :245-251
[6]   DOWNS-SYNDROME AND THE MOLECULAR-BIOLOGY OF CHROMOSOME-21 [J].
COOPER, DN ;
HALL, C .
PROGRESS IN NEUROBIOLOGY, 1988, 30 (06) :507-530
[7]  
CUCKLE HS, 1988, LANCET, V2, P851
[8]  
CUNNINGHAM FG, 1993, WILLIAMS OBSTETRICS, P919
[9]  
Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114
[10]   ISOLATION, CLONING AND SEQUENCE-ANALYSIS OF THE CDNA FOR THE ALPHA-SUBUNIT OF HUMAN CHORIONIC-GONADOTROPIN [J].
FIDDES, JC ;
GOODMAN, HM .
NATURE, 1979, 281 (5730) :351-356